In March 1998, the Food And Drug Administration provided its press into the erection dysfunction medication Viagra and, from the time, pharmaceutical businesses have already been wanting to create a counterpart that is female.

But while Viagra tackles the technical end of males’s intimate dissatisfaction, increasing the flow of blood to be able to help and keep erections, the look for its feminine counterpart have not frequently dedicated to the similarly mechanical, usually debilitating conditions impacting ladies, like vaginismus, chronic dryness or dyspareunia?. Rather, pharmaceutical research has centered on increasing the feminine libido, providing a remedy for a disorder frequently described as hypoactive desire disorder that is sexual. Continue reading →